Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/132803
| Title: | Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC) | Authors: | Garassino, Marina Chiara Wakelee, Heather A. Spicer, Jonathan Liberman, Moishe Kato, Terufumi Tsuboi, Masahiro Lee, Se-Hoon Chen, Ke-Neng Dooms, Christophe Alfons Majem, Margarita Eigendorff, Ekkehard Martinengo, Gaston L. Bylicki, Olivier Rodríguez Abreu, Delvys Chaft, Jamie E. Yang, Jing Arunachalam, Ashwini Norquist, Josephine M. Keller, Steven M. Gao, Shugeng |
UNESCO Clasification: | 32 Ciencias médicas 320713 Oncología 3209 Farmacología |
Issue Date: | 2024 | Journal: | Journal of Clinical Oncology | Conference: | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) | URI: | http://hdl.handle.net/10553/132803 | ISSN: | 0732-183X | Source: | Journal Of Clinical Oncology[ISSN 0732-183X],v. 42 (16) sup. S, Abstract 8012, (Junio 2024) |
| Appears in Collections: | Actas de congresos |
Page view(s)
44
checked on Jan 11, 2025
Download(s)
59
checked on Jan 11, 2025
Google ScholarTM
Check
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.